Home Disclaimer


The ideas and opinions expressed in IASLC Lung Cancer News do not necessarily reflect those of the International Association for the Study of Lung Cancer. The mention of any product, service, or therapy in this website should not be construed as an endorsement. Appropriate treatment for patients is the responsibility of their treating physicians and other health-care providers who rely on independent experience and knowledge of the patient. The appropriate medical literature and current product information should be checked by readers concerning verification of dosage, method, and duration of administration, or contraindications. The International Association for the Study of Lung Cancer accepts no responsibility for any injury or damage to person or persons arising out of or related to any errors, omissions, or use of material contained in this website.

- Advertisement -


Ongoing Clinical Challenges: Defining Immunotherapy Benefit for Patients With NSCLC and...

By Valérie Gounant, MD, and Elisabeth Quoix, MD, PhD Posted: December 11, 2019 This article is the first in a two-part series on ongoing challenges using...